Diverging the anthracycline class of anti-cancer drugs for superior survival of acute myeloid leukemia patients

Xiaohang Qiao; Sabina Y. van der Zanden; Xiaoyang Li; Minkang Tan; Yunxiang Zhang; Ji-Ying Song; Merle A. van Gelder; Feija L. Hamoen; Lennert Janssen; Charlotte L. Zuur; Baoxu Pang; Olaf van Tellingen; Junmin Li; Jacques Neefjes

doi:10.1101/2023.11.23.23298950

Diverging the anthracycline class of anti-cancer drugs for superior survival of acute myeloid leukemia patients

Xiaohang Qiao, Sabina Y. van der Zanden, Xiaoyang Li, Minkang Tan, Yunxiang Zhang, Ji-Ying Song, Merle A. van Gelder, Feija L. Hamoen, Lennert Janssen, Charlotte L. Zuur, Baoxu Pang, Olaf van Tellingen, Junmin Li, Jacques Neefjes

doi: https://doi.org/10.1101/2023.11.23.23298950

Xiaohang Qiao

1Division of Tumor Biology and Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands

2Department of Head and Neck Oncology and Surgery, The Netherlands Cancer Institute, Amsterdam, The Netherlands

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: x.qiao@nki.nl drlijunmin@126.com j.j.c.neefjes@lumc.nl

Sabina Y. van der Zanden

3Department of Cell and Chemical Biology, ONCODE Institute, Leiden University Medical Center, Leiden, The Netherlands

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Xiaoyang Li

4Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine, Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Minkang Tan

3Department of Cell and Chemical Biology, ONCODE Institute, Leiden University Medical Center, Leiden, The Netherlands

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Yunxiang Zhang

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ji-Ying Song

6Division of Experimental Animal Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Merle A. van Gelder

3Department of Cell and Chemical Biology, ONCODE Institute, Leiden University Medical Center, Leiden, The Netherlands

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Feija L. Hamoen

3Department of Cell and Chemical Biology, ONCODE Institute, Leiden University Medical Center, Leiden, The Netherlands

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Lennert Janssen

3Department of Cell and Chemical Biology, ONCODE Institute, Leiden University Medical Center, Leiden, The Netherlands

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Charlotte L. Zuur

1Division of Tumor Biology and Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands

2Department of Head and Neck Oncology and Surgery, The Netherlands Cancer Institute, Amsterdam, The Netherlands

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Baoxu Pang

3Department of Cell and Chemical Biology, ONCODE Institute, Leiden University Medical Center, Leiden, The Netherlands

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Olaf van Tellingen

5Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Junmin Li

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: x.qiao@nki.nl drlijunmin@126.com j.j.c.neefjes@lumc.nl

Jacques Neefjes

3Department of Cell and Chemical Biology, ONCODE Institute, Leiden University Medical Center, Leiden, The Netherlands

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: x.qiao@nki.nl drlijunmin@126.com j.j.c.neefjes@lumc.nl

Abstract
Full Text
Info/History
Metrics
Supplementary material
Data/Code
Preview PDF

Supplementary Materials[supplements/298950_file08.docx]

View the discussion thread.

PreviousNext

Posted November 24, 2023.

Download PDF

Supplementary Material

Data/Code

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Diverging the anthracycline class of anti-cancer drugs for superior survival of acute myeloid leukemia patients

Message Subject (Your Name) has forwarded a page to you from medRxiv

Message Body (Your Name) thought you would like to see this page from the medRxiv website.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Diverging the anthracycline class of anti-cancer drugs for superior survival of acute myeloid leukemia patients

medRxiv 2023.11.23.23298950; doi: https://doi.org/10.1101/2023.11.23.23298950

Share This Article:

Citation Tools

Diverging the anthracycline class of anti-cancer drugs for superior survival of acute myeloid leukemia patients

medRxiv 2023.11.23.23298950; doi: https://doi.org/10.1101/2023.11.23.23298950

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Tweet Widget
Facebook Like
Google Plus One

Subject Area

Oncology

Subject Areas

All Articles

Addiction Medicine (386)
Allergy and Immunology (701)
Anesthesia (193)
Cardiovascular Medicine (2859)
Dentistry and Oral Medicine (326)
Dermatology (244)
Emergency Medicine (431)
Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1011)
Epidemiology (12569)
Forensic Medicine (10)
Gastroenterology (807)
Genetic and Genomic Medicine (4447)
Geriatric Medicine (402)
Health Economics (716)
Health Informatics (2856)
Health Policy (1050)
Health Systems and Quality Improvement (1050)
Hematology (376)
HIV/AIDS (893)
Infectious Diseases (except HIV/AIDS) (13986)
Intensive Care and Critical Care Medicine (831)
Medical Education (415)
Medical Ethics (114)
Nephrology (464)
Neurology (4201)
Nursing (223)
Nutrition (617)
Obstetrics and Gynecology (788)
Occupational and Environmental Health (723)
Oncology (2205)
Ophthalmology (626)
Orthopedics (254)
Otolaryngology (319)
Pain Medicine (269)
Palliative Medicine (83)
Pathology (488)
Pediatrics (1172)
Pharmacology and Therapeutics (489)
Primary Care Research (483)
Psychiatry and Clinical Psychology (3658)
Public and Global Health (6787)
Radiology and Imaging (1494)
Rehabilitation Medicine and Physical Therapy (869)
Respiratory Medicine (902)
Rheumatology (430)
Sexual and Reproductive Health (433)
Sports Medicine (369)
Surgery (473)
Toxicology (57)
Transplantation (202)
Urology (174)